Myriad Genetics, Inc. Partners With Mammography Reporting System, Inc. to Increase Identification of High Risk Breast Cancer Patients

SALT LAKE CITY, Jan. 6, 2010 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today it has entered into an agreement with Mammography Reporting System, Inc. (MRS) to help increase the identification of patients at high risk for hereditary breast cancer.